Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan
- PMID: 30233166
- PMCID: PMC6130534
- DOI: 10.2147/COPD.S172679
Prevalence of undiagnosed COPD in male patients with coronary artery disease: a cross-sectional study in Jordan
Abstract
Purpose: COPD and coronary artery disease (CAD) are common chronic diseases with shared risk factors. COPD continues to be largely underdiagnosed and undertreated. We aimed to describe the prevalence and predictors of undiagnosed COPD in Jordanian men with CAD.
Patients and methods: In a cross-sectional study conducted at a referral center in Jordan, male patients who underwent coronary angiography for suspected CAD and reported ≥10 pack-year of cigarette smoking were recruited. Pre- and post-bronchodilator spirometry was undertaken for all participants, and COPD was defined as post-bronchodilator FEV1/FVC <70%. The finding of ≥50% coronary luminal narrowing confirmed the presence of CAD.
Results: Spirometry was undertaken for 376 men with mean age of 56.02±10.55 years, and 72.6% were active cigarettes smokers with a mean pack-year of 55.89±34.25. A CAD diagnosis was confirmed in 300 (79.8%) men. Spirometric criteria for COPD were met in 76 (15.7%) patients, of whom 91.5% were not previously diagnosed. COPD-related symptoms were common: chronic cough (44.4%), dyspnea (66.2%), and wheezes (27.9%). COPD was more common in patients with (18.0%) compared to patients without (6.6%) CAD (P=0.014). Multivariate logistic regression showed that the risk of COPD was higher in patients with CAD (OR 3.16, 95% CI, 1.10-9.09, P=0.033) and in those with chronic bronchitis (OR 13.07, 95% CI, 6.69-25.52, P<0.001).
Conclusion: There was a high prevalence of COPD among male patients with CAD and most were underdiagnosed despite having respiratory symptoms. Male smokers with CAD and respiratory symptoms should be evaluated for airflow limitation and the presence of COPD.
Keywords: COPD; airflow limitation; cardiovascular disease; coronary catheterization; spirometry.
© 2018 Khassawneh et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia.Respir Med. 2021 Apr;179:106335. doi: 10.1016/j.rmed.2021.106335. Epub 2021 Feb 16. Respir Med. 2021. PMID: 33621707
-
Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan.Int J Chron Obstruct Pulmon Dis. 2014 Jul 17;9:753-8. doi: 10.2147/COPD.S62898. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 25092972 Free PMC article.
-
Impact of active and passive smoking as risk factors for asthma and COPD in women presenting to primary care in Syria: first report by the WHO-GARD survey group.Int J Chron Obstruct Pulmon Dis. 2013;8:473-82. doi: 10.2147/COPD.S50551. Epub 2013 Oct 2. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24124359 Free PMC article.
-
Undiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress.Respirology. 2016 Jan;21(1):137-42. doi: 10.1111/resp.12668. Epub 2015 Oct 29. Respirology. 2016. PMID: 26510536
-
Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers.Int J Chron Obstruct Pulmon Dis. 2019 Jul 22;14:1633-1638. doi: 10.2147/COPD.S204190. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31413558 Free PMC article.
Cited by
-
Global Insights into Chronic Obstructive Pulmonary Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis of 6,400,000 Patients.Rev Cardiovasc Med. 2024 Jan 15;25(1):25. doi: 10.31083/j.rcm2501025. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077650 Free PMC article.
-
Chronic obstructive pulmonary disease patients' quality of life and its related factors: A cross-sectional study of the Jordanian population.F1000Res. 2022 May 26;11:581. doi: 10.12688/f1000research.121783.1. eCollection 2022. F1000Res. 2022. PMID: 35811805 Free PMC article.
-
Video-based teach-to-goal intervention on inhaler technique on adults with asthma and COPD: A randomized controlled trial.PLoS One. 2023 Jun 9;18(6):e0286870. doi: 10.1371/journal.pone.0286870. eCollection 2023. PLoS One. 2023. PMID: 37294823 Free PMC article. Clinical Trial.
-
The Burden of Chronic Obstructive Pulmonary Disease in Cardiovascular Diseases: A Non-Western Perspective.Tuberc Respir Dis (Seoul). 2021 Apr;84(2):167-170. doi: 10.4046/trd.2020.0151. Epub 2021 Feb 17. Tuberc Respir Dis (Seoul). 2021. PMID: 33596375 Free PMC article. No abstract available.
-
Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.Int J Chron Obstruct Pulmon Dis. 2022 Oct 14;17:2577-2587. doi: 10.2147/COPD.S373853. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36267326 Free PMC article.
References
-
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). The Global Strategy for the Diagnosis, Management and Prevention of COPD; 2017. Available from: http://goldcopd.org. Accessed May 20, 2017.
-
- Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. - PubMed
-
- Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe 2014: epidemiological update. Eur Heart J. 2014;35(42):2929–2959. - PubMed
-
- Celli BR, Locantore N, Yates J, et al. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10):1065–1072. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous